New rules for distributing liver grafts;Nouvelles règles d'attribution des greffons hépatiques

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 6-7, 2008, Pages 585-588

  Calmus, Y ^a   Jacquelinet, C ^b  

^a hôpital Cochin ^*  (France)

^b Agence de la Biomedecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROTHROMBIN; THROMBOPLASTIN; VITAMIN K GROUP;

BIOMEDICINE; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; EDITORIAL; GRAFT PATENCY; GRAFT SURVIVAL; HOSPITAL ADMISSION; HYPERBILIRUBINEMIA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MORTALITY; PRACTICE GUIDELINE;

FRANCE; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT;

EID: 50349098338     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.01.038     Document Type: Editorial

References (12)

1. Agence de la biomédecine. Activité régionale de prélèvement et de greffe. Paris, 2007. http://www.agence-biomedecine.fr/fr/experts/doc/rapp-synth2006.pdf.
2. Dunbavand A., Cohen S., Jacquelinet C., Chalem Y., and Tuppin P. Variations géographiques de l'accès à la greffe de foie en France. Gastroenterol Clin Biol 26 (2002) 123-129
3. Granger B, Savoye E, Tenaillon A, Loty B, Tuppin P. Facteurs expliquant les disparités régionales d'inscription en liste d'attente de greffe hépatique en France. Gastroenterol Clin Biol 2008, in press.
4. Webb K., Shepherd L., Day E., Masterton G., and Neuberger J. Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl 12 (2006) 301-305
5. Olthoff K.M., Brown Jr. R.S., Delmonico F.L., Freeman R.B., McDiarmid S.V., Merion R.M., et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 10 Suppl. 2 (2004) A6-A22
6. Kamath P.S., and Ray Kim W. The model for end-stage liver disease (MELD). Hepatology 45 (2007) 797-805
7. Wiesner R.H., Freeman R.B., and Mulligan D.C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127 (2004) S261-S267
8. Luca A., Angermayr B., Bertolini G., Koenig F., Vizzini G., Ploner M., et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 13 (2007) 1174-1180
9. Cholongitas E., Marelli L., Kerry A., Senzolo M., Goodier D.W., Nair D., et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 13 (2007) 523-529
10. Ravaioli M., Masetti M., Ridolfi L., Capelli M., Grazi G.L., Venturoli N., et al. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation 83 (2007) 919-924
11. Bellest L., Eschwège V., Poupon R., Chazouillères O., and Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 46 (2007) 528-534
12. Silberhumer G.R., Pokorny H., Hetz H., Herkner H., Rasoul-Rockenschaub S., Soliman T., et al. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation 83 (2007) 588-592